insig indapamide hemihydrate 2.5mg sugar coated tablet blister pack
arrotex pharmaceuticals pty ltd - indapamide hemihydrate, quantity: 2.5 mg - tablet, sugar coated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; shellac; white beeswax; carnauba wax - management of essential hypertension. it may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. normally indapamide is used as the initial agent in multiple drug regimens.
malvin liquid
deseret biologicals, inc. - malvin (unii: i9i120531l) (malvin - unii:i9i120531l) - malvin 15 [hp_c] in 1 ml - for temporary relief of symptoms related to malvin sensitivities including headache, nasal and sinus congestion, rash, painful joints and hyperactivity.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to malvin sensitivities including headache, nasal and sinus congestion, rash, painful joints and hyperactivity.
proflavine 0.1% cream
a a h pharmaceuticals ltd - proflavine hemisulfate - cutaneous cream - 1mg/1gram
proflavine 0.1% cream
j m loveridge ltd - proflavine hemisulfate - cutaneous cream - 1mg/1gram
proflavine 0.1% cream
alliance healthcare (distribution) ltd - proflavine hemisulfate - cutaneous cream - 1mg/1gram
proflavine hemisulfate
virbac (australia) pty ltd - proflavine hemisulfate - unknown - proflavine hemisulfate anilide/aniline active 0.0 - active constituent
riboflavin 5' phosphate sodium
ceva animal health pty ltd - riboflavin-5-phosphate sodium - unknown - riboflavin-5-phosphate sodium vitamin-b2 active 0.0 - active constituent
acriflavine emulsion
resmed pharmaceuticals - acriflavine bpc - emulsion - acriflavine bpc 0.10g/100ml
halaven
eisai gmbh - eribulin - breast neoplasms; liposarcoma - antineoplastic agents - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimens for advanced disease (see section 5.1). prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease (see section 5.1).
acriflavine
psm healthcare ltd trading as api consumer brands - acriflavine 0.1%{relative} - topical solution - 0.1% w/v - active: acriflavine 0.1%{relative}